Product Information
VORICONAZOLE 200 MG VIAL is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $28.7741 per EA under NDC 70436002980. Its NADAC has been published 23 times since Jan 22, 2025.
FDA first approved this application on Nov 30, 2018. Its Orange Book therapeutic-equivalence code is AP.
Strength
200 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436002980
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
6/18/2025
Active Ingredients
VORICONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA211661FDA Approved
11/30/2018
TE Code
AP
On Market Since
1/28/2019
Pharmacological Classes
Price Statistics
The NADAC for VORICONAZOLE 200 MG VIAL has been published 23 times since Jan 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $28.7741 per EA |
|---|---|
| All-time high | $29.8465 (Mar 12, 2025) |
| All-time low | $27.8681 (May 21, 2025) |
| Median price | $28.8851 |
| Average price | $28.8022 |
| Largest weekly change | +3.3% (Jun 18, 2025) |
| Weeks tracked | 23 |
| Tracking since | Jan 22, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-1.8%
Last surveyed Jun 25, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the voriconazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Slate Run Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
voriconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VORICONAZOLE 200 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for VORICONAZOLE 200 MG VIAL, manufactured by Slate Run Pharmaceuticals LLC, is $28.7741 per EA (NDC 70436002980), effective Jun 25, 2025.
How has the price of VORICONAZOLE 200 MG VIAL changed over time?
Over the history we have for it, the NADAC for VORICONAZOLE 200 MG VIAL has held within roughly two percent of its current level. It has been tracked across 23 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for VORICONAZOLE 200 MG VIAL?
Since Jan 22, 2025, the NADAC for VORICONAZOLE 200 MG VIAL has ranged from a low of $27.8681 (May 21, 2025) to a high of $29.8465 (Mar 12, 2025), with a median of $28.8851 per EA.
Are there cheaper alternatives to VORICONAZOLE 200 MG VIAL?
No other NADAC-published product currently shares the active ingredient and strength of VORICONAZOLE 200 MG VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VORICONAZOLE 200 MG VIAL?
VORICONAZOLE 200 MG VIAL (NDC 70436002980) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.